Genomic Vision Celebrates Euronext Paris Listing
EnterNext has congratulated biotechnology company, Genomic Vision on its successful listing in compartment C of Euronext’s regulated market in Paris.Read more.
Investors to Profit Strongly From IPOs
New research from Capita Asset Services shows investors who buy into an IPO would see their returns outstrip the widerRead more.
CGE Warns About Dangers of Derivatives
The Certified Gold Exchange is warning investors about the correlation between computerised trading of gold derivatives investments and the valueRead more.
Never Too Late
Global high-yield bonds gain popularity in Thailand, but retail investors so far sidelinedRead more.
LSE Sees Increase in Retail IPO Activity
London Stock Exchange has welcomed seven new retail companies to its markets, raising £2.1bn, in the first few months ofRead more.
Food Retailers Feel the Aldi/Lidl Squeeze
Ahead of Sainsbury’s full year results, Michael Hewson takes a critical look at its performance and how the new kidsRead more.
Time to Buy Emerging Markets Again?
Following the recent sell-off in emerging markets, there is a view developing that now is the time to invest.Read more.
Stephen Campbell on the Growth Capital Market
Stephen Campbell, Partner of Panoramic Growth Equity, gives his predictions on the growth capital market in 2014Read more.
Global AUM to Exceed $100tn
Research from PwC predicts that global assets under management (AuM) will rise to around $101.7 trillion by 2020, from aRead more.
UK Investors are Underweight
The majority (50%) of UK independent financial advisers (IFAs) believe sophisticated investors are underweight in the venture capital sector accordingRead more.